Current Assets
Work in process
Eli Lilly Work in process increased by 3.3% to $8.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.7%, from $5.30B to $8.46B. Over 2 years (FY 2023 to FY 2025), Work in process shows an upward trend with a 58.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ1 2026Apr 30, 2026
Parent metricInventories
How to read this metric
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Detailed definition
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peer comparison
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
Metric ID:
inv_work_in_progressHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.25B | $3.61B | $3.71B | $4.04B | $3.98B | $5.30B | $6.51B | $7.27B | $8.18B | $8.46B |
| QoQ Change | — | +11.2% | +2.6% | +8.9% | -1.4% | +33.1% | +22.9% | +11.8% | +12.5% | +3.3% |
| YoY Change | — | — | — | — | +22.5% | +46.6% | +75.6% | +80.3% | +105.6% | +59.7% |
| % of Inventories | 57.3% | 60.1% | 58.0% | 54.6% | 52.9% | 57.1% | 59.1% | 59.5% | 59.7% | 58.3% |
| Share Change | — | +2.9pp | -2.2pp | -3.3pp | -1.8pp | +4.2pp | +2.0pp | +0.4pp | +0.2pp | -1.4pp |
Range$3.25B – $8.46B
CAGR+53.0%
Avg YoY Growth+65.1%
Median YoY Growth+67.6%
Current Streak5 quarters growth
Work in process at Other Companies
Frequently Asked Questions
- What is Eli Lilly's work in process?
- Eli Lilly (LLY) reported work in process of $8.46B in Q1 2026.
- How has Eli Lilly's work in process changed year-over-year?
- Eli Lilly's work in process increased by 59.7% year-over-year, from $5.30B to $8.46B.
- What is the long-term trend for Eli Lilly's work in process?
- Over 2 years (2023 to 2025), Eli Lilly's work in process has grown at a 58.7% compound annual growth rate (CAGR), from $3.25B to $8.18B.
- What does work in process mean?
- The value of goods currently in the middle of the manufacturing process.